Chief Medical Officer of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Baldo Lance, sells 6,250 shares worth $315,088
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 09 07:05 PM, company Chief Medical Officer, Baldo Lance disclosed selling 6,250 shares at a cost of $50.41. At the time of this transaction (Dec 07), this trade was worth $315,088 in total. As of Dec 07, Baldo Lance now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) Chief Medical Officer, Baldo Lance, we have the following information:
- SEC Form 4 filing: Sep 29: Sold 25,000 shares at the rate of $50.00 per share. Total worth of this trade was $1,250,000. Total number of shares owned as of Sep 29 were 0
- SEC Form 4 filing: Sep 10: Sold 18 shares at the rate of $40.00 per share. Total worth of this trade was $720. Total number of shares owned as of Sep 10 were 0
- SEC Form 4 filing: Sep 11: Sold 4,149 shares at the rate of $40.00 per share. Total worth of this trade was $165,960. Total number of shares owned as of Sep 11 were 0
Posted by
George Daniels
on Thursday December 10 2020, 8:50 AM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
